INM

InMed Pharmaceuticals Inc (INM)

US
$ 3.00990.67%

Price Chart

Key Statistics

Market Cap
$ 4.08M
P/E Ratio
0.00
Revenue (TTM)
$ 4.92M
Volume
14.39K
52W High
$ 9.38
52W Low
$ 1.72
Dividend Yield
0.00%
Beta
0.28

Technicals

50-Day MA
2.8591
200-Day MA
3.7727
52 Week High
9.376
52 Week Low
1.72

About INM

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

Employees
13
Headquarters
Vancouver, BC
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg